LUPKYNIS (U.S. Trademark Serial Number 88672395) is a United States trademark of Aurinia Pharmaceuticals Inc.. The goods and services include: Pharmaceutical preparations for the treatment of kidney disorders, lupus nephritis, and focal segmental glomerulosclerosis . The correspondent is Matthew R. Wilmot of STOEL RIVES LLP.
This trademark was filed on October 29, 2019 as United States Trademark Application Serial Number 88672395. The trademark application was registered on June 22, 2021 as U.S. Trademark Registration 6397451.
Trademark PTO Status History
June 22, 2021 – REGISTERED-PRINCIPAL REGISTER
May 18, 2021 – NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
May 17, 2021 – ALLOWED PRINCIPAL REGISTER – SOU ACCEPTED
May 16, 2021 – STATEMENT OF USE PROCESSING COMPLETE
May 05, 2021 – USE AMENDMENT FILED
May 15, 2021 – CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 05, 2021 – TEAS STATEMENT OF USE RECEIVED
October 10, 2020 – NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
View full trademark status information at USPTO
Ownership History
Aurinia Pharmaceuticals Inc.
Aurinia Pharmaceuticals Inc.
Aurinia Pharmaceuticals Inc.
View documents on file at USPTO
File a Trademark or Get Help With Trademark Law
Select IP monitors top trademarks which have been allowed and granted worldwide. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.